- Abstract Number: 1044
JAK inhibition reprograms macrophages toward immune tolerance but impairs tumor immune surveillance through CD47-SIRPα signaling
- Abstract Number: 0573
JAK Inhibitor-Centered Therapy Improves Inflammatory Control and Cardiopulmonary Outcomes in Refractory Still’s Disease with Lung Disease and Drug-Associated Immune Reaction
- Abstract Number: 2591
JAK Inhibitors in Dermatomyositis: A Real-World Propensity-Matched Analysis of Mortality and Cardiovascular Outcomes
- Abstract Number: 0176
JAK Inhibitors in Giant Cell Arteritis: A Systematic Review and Meta-Analysis Supporting Upadacitinib Efficacy and Glucocorticoid Reduction
- Abstract Number: 2592
JAK Inhibitors Versus Standard Immunosuppressants in Dermatomyositis/Polymyositis-Associated Interstitial Lung Disease: A Propensity-Matched Federated Network Cohort Study
- Abstract Number: 2403
JAK Inhibitors Versus TNF Inhibitors and Risk of Incident Type 2 Diabetes in Biologic-Naive Rheumatoid Arthritis: A Propensity Score-Matched Real World Cohort Study
- Abstract Number: 2367
Janus Kinase Inhibition in Sjögren’s Disease: Safety and Spatial Molecular Endotyping of a Phase Ib-IIa Trial
- Abstract Number: 0084
Janus Kinase Inhibitors Rapidly Reduce T-Cell Immunosenescence and Epigenetic Age Acceleration in Rheumatoid Arthritis
- Abstract Number: 1109
JMB-2502, a Novel and Potent Anti-BAFF (B-Cell Activating Factor)/APRIL (A Proliferation-Inducing Ligand) Bispecific Antibody with an Extended Half-Life for the Treatment of SLE and Other B-Cell-Related Autoimmune Diseases
- Abstract Number: 1347
Joint Pain is Associated with Worse Patient-Reported Outcomes Independent of Intestinal Disease Activity in Patients with Inflammatory Bowel Disease
- Abstract Number: 2649
JUD-001 a novel kidney targeted siRNA therapeutic for treating Gout
- Abstract Number: 1513
Juvenile systemic sclerosis with dermatomyositis-like overlap features represents a distinct clinical phenotype: updates from the Juvenile Scleroderma Inception Cohort
- Abstract Number: 2498
Juvenile-Onset Behçet’s Disease: Distinct Clinical Phenotype and HLA-B51 Association in a Cohort of 250 Patients
- Abstract Number: 0203
Juvenile-Onset Granulomatosis with Polyangiitis: A Distinctive Entity with Predominant Gastrointestinal Involvement
ACR Convergence 2026
November 6-11, 2026. Orlando, Florida.